eMIMSplus Asia vs Cureiosity
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
eMIMSplus Asia
Read full descriptionHide full description
With over 60 years of being the go-to medicine information provider, CIMS Medica/MIMS presents the most comprehensive and easy-to-use digital medicine and drug reference platform — eMIMSplus. eMIMSplus provides access to over 100,000 drugs approved in India, presented in a clinically relevant format, along with the following key features: 1. MIMS Interaction Checker to identify: a. Potentially harmful combinations of medicines b. Medicines that may be unsuitable due to the patient’s allergy profile c. Medicines that may be unsuitable due to a pre-existing health condition 2. A compilation of regionally and internationally referenced Disease Management Guides across more than 16 specialties 3. Clinical Tables, classified by category of medicine 4. CME/CPD (accredited and unaccredited) courses available online 5. MIMS Medical News & Updates 6. Medicine Interactions involving Cytochrome P450 enzymes 7. Clinical Calculators, equations, and scoring tools across 15 categories 8. Future tools to help identify medicines that may be potentially unsafe during pregnancy or lactation 9. A medicine database updated quarterly Safer Medicines, Better Care Disclaimer: eMIMSplus is strictly intended for use by healthcare professionals — including doctors, nurses, pharmacists, and medical students. For more information: https://cds.mims.com/emimsplus/ To access the platform: https://cds.emims.plus/ For support: subscriptions.cds@cims.co.in Phone: +918064532805/+918064532806 Available: Monday to Friday, 10:00 AM – 6:00 PM IST
Cureiosity
Discover and learn about clinical trials with personalized recommendations and clear explanations. Make informed decisions about participating in research with up-to-date trial information.
- Personalized clinical trial recommendations
- Clear explanations of trial information
- Up-to-date trial data
- User-friendly interface
- Informed decision-making support
Read full descriptionHide full description
Cureiosity connects you with clinical trials from leading research institutions. Whether you're looking to contribute to medical breakthroughs, explore innovative treatment options, or find paid research studies, Cureiosity helps you discover opportunities that fit your interests. With easy to understand study information, you can explore opportunities and make informed decisions with confidence.
Screenshots
Verdict
The clearest difference is update cadence: Cureiosity at monthly against eMIMSplus Asia's every 4 months. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
eMIMSplus Asia ships an update every 4 months, Cureiosity monthly. The most recent releases landed on October 19, 2026 and October 7, 2026 respectively.
| Parameter | eMIMSplus Asia | Cureiosity |
|---|---|---|
| Price | Free | Free |
| Rating | — | 5.0 (1 ratings) — better |
| Number of ratings | — | 1 — better |
| Update frequency | Every 4 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.1 | 15.1 |
| Further details — not scored | ||
| Size | 18 MB | 33 MB |
| Age rating | 17+ | 17+ |
| Developer | MIMS PTE. LTD. | Cureiosity Inc. |
In-app purchases
eMIMSplus Asia
No in-app purchases
Cureiosity
No in-app purchases
Questions
Is eMIMSplus Asia free?
Is Cureiosity free?
Do eMIMSplus Asia or Cureiosity have ads?
Which is updated more often, eMIMSplus Asia or Cureiosity?
Other comparisons
